{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T02:00:59Z","timestamp":1768010459117,"version":"3.49.0"},"reference-count":43,"publisher":"Wiley","issue":"18","license":[{"start":{"date-parts":[[2003,8,14]],"date-time":"2003-08-14T00:00:00Z","timestamp":1060819200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Biochemistry"],"published-print":{"date-parts":[[2003,9]]},"abstract":"<jats:p>Intravenous iron, used for the treatment of anemia in chronic renal failure and other diseases, represents a possible source of free iron in tissue cells, particularly in the liver. In this study we examined the effect of different sources of intravenous iron (IVI) on the labile iron pool (LIP) which represents the nonferritin\u2010bound, redox\u2010active iron that is implicated in oxidative stress and cell injury. Furthermore, we examined the role of the LIP for the synthesis of ferritin. We used HepG2 cells as a well known model for hepatoma cells and monitored the LIP with the metal\u2010sensitive fluorescent probe, calcein\u2010AM, the fluorescence of which is quenched on binding to iron. We showed that steady state LIP levels in HepG2 cells were increased transiently, up to three\u2010fold compared to control cells, as an adaptive response to long\u2010term IVI exposure. In relation to the amount of iron in the LIP, the ferritin levels increased and the iron content of ferritin decreased. As any fluctuation in the LIP, even when it is only transient (e.g. after exposure to intravenous iron in this study), may result either in impairment of synthesis of iron containing proteins or in cell injury by pro\u2010oxidants. Such findings in nonreticuloendothelial cells may have important implications in the generation of the adverse effects of chronic iron exposure reported in dialysis patients.<\/jats:p>","DOI":"10.1046\/j.1432-1033.2003.03759.x","type":"journal-article","created":{"date-parts":[[2003,8,29]],"date-time":"2003-08-29T13:54:21Z","timestamp":1062165261000},"page":"3731-3738","source":"Crossref","is-referenced-by-count":24,"title":["Transient increase of the labile iron pool in HepG2 cells by intravenous iron preparations"],"prefix":"10.1111","volume":"270","author":[{"given":"Brigitte","family":"Sturm","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Goldenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Scheiber\u2010Mojdehkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2003,8,14]]},"reference":[{"key":"e_1_2_22_2_2","first-page":"2070","article-title":"Importance of iron supply for erythropoietin therapy","volume":"10","author":"Sunder\u2010Plassmann G.","year":"1995","journal-title":"Nephrol. Dial. Transplant."},{"key":"e_1_2_22_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(99)70103-4"},{"key":"e_1_2_22_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/16.suppl_5.50"},{"key":"e_1_2_22_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/13.1.82"},{"key":"e_1_2_22_6_2","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2002.33917"},{"key":"e_1_2_22_7_2","first-page":"1439","article-title":"Structure\/histotoxicity relationship of parenteral iron","volume":"42","author":"Geisser P.","year":"1992","journal-title":"Drug Res."},{"key":"e_1_2_22_8_2","doi-asserted-by":"publisher","DOI":"10.1067\/mlc.2000.110368"},{"key":"e_1_2_22_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-2952(03)00181-3"},{"key":"e_1_2_22_10_2","first-page":"615","article-title":"Pharmacokinetics of iron (III)\u2010sucrose complex after a single intravenous dose in healthy volunteers","volume":"46","author":"Danielson B.G.","year":"1996","journal-title":"Drug. Res."},{"key":"e_1_2_22_11_2","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1681\/ASN.V133734","article-title":"Iron administration and clinical outcomes in hemodialysis patients","volume":"13","author":"Feldman H.I.","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"key":"e_1_2_22_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00191543"},{"key":"e_1_2_22_13_2","doi-asserted-by":"publisher","DOI":"10.3109\/10408418809104468"},{"key":"e_1_2_22_14_2","first-page":"27","article-title":"Impairment of phagocyte oxidative metabolism in hemodialyzed patients with iron overload","volume":"25","author":"Flament J.","year":"1986","journal-title":"Clin. Nephrol."},{"key":"e_1_2_22_15_2","first-page":"524","article-title":"Impaired neutrophil defense against Cersinis enterocolitica in patients with iron overload who are undergoing dialysis","volume":"111","author":"Cantinieaux B.","year":"1988","journal-title":"J. Laboratory Clin. Med."},{"key":"e_1_2_22_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/5.7.504"},{"key":"e_1_2_22_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(12)80454-9"},{"key":"e_1_2_22_18_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V94655"},{"key":"e_1_2_22_19_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2362.2002.0320s1009.x"},{"key":"e_1_2_22_20_2","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2002.36334"},{"key":"e_1_2_22_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(85)90322-5"},{"key":"e_1_2_22_22_2","first-page":"1025","article-title":"Iron overload, but not treatment with desferrioxamine favours the development of septemia in patients on maintenance hemodialysis","volume":"65","author":"Seifert A.","year":"1987","journal-title":"Q. J. Med."},{"key":"e_1_2_22_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/5.2.130"},{"key":"e_1_2_22_24_2","first-page":"377","article-title":"Risk factors for bacterial infections in chronic hemodialysis adult patients: a multicenter prospective survey","volume":"10","author":"Hoen B.","year":"1995","journal-title":"Nephrol. Dial. Transplant."},{"key":"e_1_2_22_25_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2362.2002.0320s1042.x"},{"key":"e_1_2_22_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(97)00056-2"},{"key":"e_1_2_22_27_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V87.5.2057.2057"},{"key":"e_1_2_22_28_2","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1182\/blood.V95.9.2960.009k13_2960_2966","article-title":"Intracellular iron status as a hallmark of mammalian cell susceptibility to oxidative stress: a study of L5178Y mouse lymphoma cell lines differentially sensitive to H2O2","volume":"95","author":"Lipinski P.","year":"2000","journal-title":"Blood"},{"key":"e_1_2_22_29_2","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/clinchem\/9.4.391","article-title":"Serum lactic dehydrogenase: an analytical assessment of current assays","volume":"9","author":"Amador E.","year":"1963","journal-title":"Clin. Chem."},{"key":"e_1_2_22_30_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00058738"},{"key":"e_1_2_22_31_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.270.41.24209"},{"key":"e_1_2_22_32_2","first-page":"190","article-title":"Frequent IV iron dosing is associated with higher infectious deaths","volume":"8","author":"Collins A.","year":"1997","journal-title":"J. Am. Soc. Nephrol."},{"key":"e_1_2_22_33_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/15.11.1743"},{"key":"e_1_2_22_34_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-139X.1999.99028.x"},{"key":"e_1_2_22_35_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V1092029"},{"key":"e_1_2_22_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/0162-0134(92)84064-T"},{"key":"e_1_2_22_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(93)90046-S"},{"key":"e_1_2_22_38_2","first-page":"4331","article-title":"Low molecular weight intracellular iron transport compounds","volume":"5","author":"Jacobs A.","year":"1977","journal-title":"Blood"},{"key":"e_1_2_22_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/0076-6879(90)86093-B"},{"key":"e_1_2_22_40_2","first-page":"703","article-title":"Cellular pool of transient ferric iron, chelatable by desferrioxamine and distinct from ferritin that is involved in oxidative cell injury","volume":"42","author":"Rothman R.J.","year":"1992","journal-title":"Mol. Pharmacol."},{"key":"e_1_2_22_41_2","first-page":"G1031","article-title":"The labile iron pool in hepatocytes: prooxidant\u2010induced increase in free iron precedes oxidative cell injury","volume":"274","author":"Staeubli A.","year":"1998","journal-title":"Am. J. Physiol."},{"key":"e_1_2_22_42_2","doi-asserted-by":"publisher","DOI":"10.1096\/fasebj.10.11.8836047"},{"key":"e_1_2_22_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(01)00222-7"},{"key":"e_1_2_22_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0891-5849(02)01006-7"}],"container-title":["European Journal of Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1432-1033.2003.03759.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/febs.onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1432-1033.2003.03759.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T17:39:30Z","timestamp":1697477970000},"score":1,"resource":{"primary":{"URL":"https:\/\/febs.onlinelibrary.wiley.com\/doi\/10.1046\/j.1432-1033.2003.03759.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,8,14]]},"references-count":43,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2003,9]]}},"alternative-id":["10.1046\/j.1432-1033.2003.03759.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1432-1033.2003.03759.x","archive":["Portico"],"relation":{},"ISSN":["0014-2956","1432-1033"],"issn-type":[{"value":"0014-2956","type":"print"},{"value":"1432-1033","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,8,14]]}}}